WallStSmart

Amrize Ltd (AMRZ)vsCRH PLC (CRH)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

CRH PLC generates 218% more annual revenue ($38.96B vs $12.26B). AMRZ leads profitability with a 10.2% profit margin vs 9.2%. AMRZ appears more attractively valued with a PEG of 1.22. AMRZ earns a higher WallStSmart Score of 62/100 (C+).

AMRZ

Buy

62

out of 100

Grade: C+

Growth: 4.0Profit: 6.5Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

CRH

Buy

55

out of 100

Grade: C-

Growth: 3.3Profit: 7.0Value: 4.7Quality: 6.0
Piotroski: 5/9Altman Z: 2.17
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AMRZ.

CRHSignificantly Overvalued (-56.4%)

Margin of Safety

-56.4%

Fair Value

$60.61

Current Price

$94.81

$34.20 premium

UndervaluedFair: $60.61Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ2 strengths · Avg: 8.0/10
Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
21.2%8/10

Strong operational efficiency at 21.2%

CRH4 strengths · Avg: 8.3/10
Market CapQuality
$60.41B9/10

Large-cap with strong market position

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.17B8/10

Generating 1.2B in free cash flow

Areas to Watch

AMRZ4 concerns · Avg: 3.8/10
Revenue GrowthGrowth
2.2%4/10

2.2% revenue growth

EPS GrowthGrowth
4.1%4/10

4.1% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

CRH3 concerns · Avg: 3.3/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Revenue GrowthGrowth
3.0%4/10

3.0% revenue growth

EPS GrowthGrowth
-15.8%2/10

Earnings declined 15.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book, Operating Margin. PEG of 1.22 suggests the stock is reasonably priced for its growth.

Bull Case : CRH

The strongest argument for CRH centers on Market Cap, P/E Ratio, Price/Book.

Bear Case : AMRZ

The primary concerns for AMRZ are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : CRH

The primary concerns for CRH are PEG Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

CRH is growing revenue faster at 3.0% — sustainability is the question.

CRH generates stronger free cash flow (1.2B), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMRZ scores higher overall (62/100 vs 55/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.

Visit Website →

CRH PLC

BASIC MATERIALS · BUILDING MATERIALS · USA

CRH plc manufactures and distributes construction materials. The company is headquartered in Dublin, Ireland.

Visit Website →

Want to dig deeper into these stocks?